Report Overview
Summary
Sinphar Pharmaceutical Co Ltd (Sinphar) is a healthcare company, which carries out the development, manufacture and sale of pharmaceutical drugs, healthy foods and cosmetics. The company’s pharmaceutical product portfolio includes a wide range of antifungal agents, anti-hypersensitive agents, cardiovascular agents, dermatologic agents, ophthalmic agents, skincare products, health supplements and others. It also has several products in pipeline addressing dementia, dry age-related macular degeneration, triple-negative breast cancer, pancreatic cancer, genital warts and others. Sinphar also offers contract manufacturing services to pharmaceutical companies for the development of new products. It has presence in China, Taiwan, Canada and other countries. Sinphar is headquartered in Tungshan, Yilan, Taiwan.
Sinphar Pharmaceutical Co Ltd (1734) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table Of Contents
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Sinphar Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Sinphar Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Sinphar Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Sinphar Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Sinphar Pharmaceutical Co Ltd, Medical Devices Deals, 2011 to YTD 2017 9
Sinphar Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Sinphar Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
SynCore Biotech to Acquire Rights to EndoTAG-1 from MediGene 11
Partnerships 12
SynCore Biotech Enters into Co-Development Contract with Aju Pharm 12
National Taiwan University Hospital Forms Joint Venture with SynCore Biotech 13
Sinphar Enters Into Co-Development Agreement With MacuCLEAR 14
Licensing Agreements 15
MediGene Expands Licensing Agreement With Syncore Biotech For Veregen 15
MediGene Enters Into Licensing Agreement With SynCore Biotechnology For EndoTAG-1 16
MediGene Enters Into Licensing Agreement With Syncore Biotech For Veregen 17
Equity Offering 18
SynCore Biotech to Raise USD8.7 Million in Rights Offering of Shares 18
SynCore Biotech to Raise USD1.1 Million in Public Offering of Shares 19
SynCore Biotech to Raise Funds through Public Offering of Shares 20
SynCore Biotech to Raise Funds through Rights Offering of Shares 21
Sinphar Pharma Announces Public Offering Of Shares For US$3.2 Million 22
Sinphar Pharma Announces Rights Issue Of US$12.6 Million 23
Sinphar Pharmaceutical Co Ltd - Key Competitors 24
Sinphar Pharmaceutical Co Ltd - Key Employees 25
Sinphar Pharmaceutical Co Ltd - Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27
List of Tables
Sinphar Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Sinphar Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Sinphar Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Sinphar Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Sinphar Pharmaceutical Co Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
Sinphar Pharmaceutical Co Ltd, Medical Devices Deals, 2011 to YTD 2017 9
Sinphar Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
SynCore Biotech to Acquire Rights to EndoTAG-1 from MediGene 11
SynCore Biotech Enters into Co-Development Contract with Aju Pharm 12
National Taiwan University Hospital Forms Joint Venture with SynCore Biotech 13
Sinphar Enters Into Co-Development Agreement With MacuCLEAR 14
MediGene Expands Licensing Agreement With Syncore Biotech For Veregen 15
MediGene Enters Into Licensing Agreement With SynCore Biotechnology For EndoTAG-1 16
MediGene Enters Into Licensing Agreement With Syncore Biotech For Veregen 17
SynCore Biotech to Raise USD8.7 Million in Rights Offering of Shares 18
SynCore Biotech to Raise USD1.1 Million in Public Offering of Shares 19
SynCore Biotech to Raise Funds through Public Offering of Shares 20
SynCore Biotech to Raise Funds through Rights Offering of Shares 21
Sinphar Pharma Announces Public Offering Of Shares For US$3.2 Million 22
Sinphar Pharma Announces Rights Issue Of US$12.6 Million 23
Sinphar Pharmaceutical Co Ltd, Key Competitors 24
Sinphar Pharmaceutical Co Ltd, Key Employees 25
Sinphar Pharmaceutical Co Ltd, Subsidiaries 26
List of Figures
Sinphar Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 2
Sinphar Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 2
Sinphar Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 2
Sinphar Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 2
Sinphar Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Sinphar Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
Sinphar Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Sinphar Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Sinphar Pharmaceutical Co Ltd, Medical Devices Deals, 2011 to YTD 2017 9